Published in Am J Drug Alcohol Abuse on May 01, 2003
Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond. Pharmacol Biochem Behav (2008) 1.36
In the Zzz zone: the effects of Z-drugs on human performance and driving. J Med Toxicol (2013) 0.99
Acute effects of zolpidem extended-release on cognitive performance and sleep in healthy males after repeated nightly use. Exp Clin Psychopharmacol (2011) 0.91
Modest abuse-related subjective effects of zolpidem in drug-naive volunteers. Behav Pharmacol (2011) 0.87
A therapeutic dose of zolpidem reduces thalamic GABA in healthy volunteers: a proton MRS study at 4 T. Psychopharmacology (Berl) (2009) 0.86
The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABA(A) receptors. Psychopharmacology (Berl) (2014) 0.81
Impaired inhibitory control of behavior in chronic cocaine users. Drug Alcohol Depend (2002) 3.15
Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies. Ann N Y Acad Sci (2010) 1.45
Individual differences in drug abuse vulnerability: d-amphetamine and sensation-seeking status. Psychopharmacology (Berl) (2006) 1.40
Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration. Psychopharmacology (Berl) (2005) 1.39
Polydrug abusers display impaired discrimination-reversal learning in a model of behavioural control. J Psychopharmacol (2005) 1.31
The reinforcing, subject-rated, performance, and cardiovascular effects of d-amphetamine: influence of sensation-seeking status. Addict Behav (2006) 1.29
Discriminative-stimulus, subject-rated, and physiological effects of methamphetamine in humans pretreated with aripiprazole. J Clin Psychopharmacol (2011) 1.22
Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans. Neuropsychopharmacology (2005) 1.21
Acute effects of oral cocaine on inhibitory control of behavior in humans. Drug Alcohol Depend (2002) 1.12
Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans. J Psychopharmacol (2004) 1.12
A pharmacological analysis of stimulant-induced increases in smoking. Psychopharmacology (Berl) (2007) 1.11
Effects of d-amphetamine on behavioral control in stimulant abusers: the role of prepotent response tendencies. Drug Alcohol Depend (2003) 1.09
Reinforcing effects of methylphenidate: influence of dose and behavioral demands following drug administration. Psychopharmacology (Berl) (2004) 1.08
Agonist replacement for stimulant dependence: a review of clinical research. Curr Pharm Des (2013) 1.08
Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans. J Pharmacol Exp Ther (2008) 1.06
Acute effects of cocaine in two models of inhibitory control: implications of non-linear dose effects. Addiction (2006) 1.04
Intranasal cocaine functions as reinforcer on a progressive ratio schedule in humans. Eur J Pharmacol (2010) 1.03
Fixation time is a sensitive measure of cocaine cue attentional bias. Addiction (2014) 1.02
Alternative reinforcer response cost impacts cocaine choice in humans. Prog Neuropsychopharmacol Biol Psychiatry (2011) 1.02
Safety, tolerability and subject-rated effects of acute intranasal cocaine administration during atomoxetine maintenance. Drug Alcohol Depend (2007) 1.02
Acute d-amphetamine pretreatment does not alter stimulant self-administration in humans. Pharmacol Biochem Behav (2007) 1.01
Monetary alternative reinforcers more effectively decrease intranasal cocaine choice than food alternative reinforcers. Pharmacol Biochem Behav (2010) 1.01
Clinical neuropharmacology of drugs of abuse: a comparison of drug-discrimination and subject-report measures. Behav Cogn Neurosci Rev (2003) 1.00
A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine. Drug Alcohol Depend (2006) 1.00
Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults. Exp Clin Psychopharmacol (2007) 0.98
Reinforcing, subject-rated, and physiological effects of intranasal methylphenidate in humans: a dose-response analysis. Drug Alcohol Depend (2003) 0.97
Discriminative stimulus and self-reported effects of methylphenidate, d-amphetamine, and triazolam in methylphenidate-trained humans. Exp Clin Psychopharmacol (2005) 0.96
Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans. Exp Clin Psychopharmacol (2006) 0.94
Methylphenidate enhances the abuse-related behavioral effects of nicotine in rats: intravenous self-administration, drug discrimination, and locomotor cross-sensitization. Neuropsychopharmacology (2007) 0.94
The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance. Am J Drug Alcohol Abuse (2007) 0.93
Human sex differences in d-amphetamine self-administration. Addiction (2010) 0.92
Reinforcing effects of d-amphetamine: influence of novel ratios on a progressive-ratio schedule. Behav Pharmacol (2010) 0.91
Wake-promoting agents with different mechanisms of action: comparison of effects of modafinil and amphetamine on food intake and cardiovascular activity. Appetite (2004) 0.89
Alcohol choice and amphetamine effects in light and moderate drinkers. Alcohol Clin Exp Res (2003) 0.89
Methylphenidate increases cigarette smoking in participants with ADHD. Psychopharmacology (Berl) (2011) 0.89
Influence of acute bupropion pre-treatment on the effects of intranasal cocaine. Addiction (2012) 0.89
Acute administration of the GABA reuptake inhibitor tiagabine does not alter the effects of oral cocaine in humans. Drug Alcohol Depend (2004) 0.89
d-Amphetamine-induced enhancement of inhibitory mechanisms involved in visual search. Exp Clin Psychopharmacol (2005) 0.89
Influence of aripiprazole pretreatment on the reinforcing effects of methamphetamine in humans. Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.88
Similar discriminative-stimulus effects of D-amphetamine in women and men. Pharmacol Biochem Behav (2007) 0.88
Baclofen does not alter the reinforcing, subject-rated or cardiovascular effects of intranasal cocaine in humans. Psychopharmacology (Berl) (2003) 0.88
Combination pharmacotherapies for stimulant use disorder: a review of clinical findings and recommendations for future research. Expert Rev Clin Pharmacol (2014) 0.87
Effects of potential agonist-replacement therapies for stimulant dependence on inhibitory control in cocaine abusers. Am J Drug Alcohol Abuse (2008) 0.86
Cocaine improves inhibitory control in a human model of response conflict. Exp Clin Psychopharmacol (2005) 0.86
Physiological and subjective effects of acute intranasal methamphetamine during extended-release alprazolam maintenance. Drug Alcohol Depend (2011) 0.85
Drug-related stimuli impair inhibitory control in cocaine abusers. Drug Alcohol Depend (2013) 0.85
Methylphenidate increases choice of cigarettes over money. Nicotine Tob Res (2010) 0.85
The influence of acute varenicline administration on smoking and eating behavior in humans. Pharmacol Biochem Behav (2008) 0.84
Oxazepam does not modulate the behavioral effects of d-amphetamine in humans. Pharmacol Biochem Behav (2005) 0.84
Methamphetamine self-administration in humans during D-amphetamine maintenance. J Clin Psychopharmacol (2014) 0.84
The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance II: increased aripipirazole dose and maintenance period. Am J Drug Alcohol Abuse (2008) 0.83
Discriminative-stimulus effects of triazolam in women and men. Am J Drug Alcohol Abuse (2006) 0.83
Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans. J Psychopharmacol (2010) 0.83
Separate and combined impact of acute naltrexone and alprazolam on subjective and physiological effects of oral d-amphetamine in stimulant users. Psychopharmacology (Berl) (2014) 0.82
Stimulant-induced changes in smoking and caloric intake: influence of rate of onset. Pharmacol Biochem Behav (2009) 0.81
Acute performance-impairing and subject-rated effects of triazolam and temazepam, alone and in combination with ethanol, in humans. J Psychopharmacol (2002) 0.81
Atomoxetine does not alter cocaine use in cocaine dependent individuals: double blind randomized trial. Drug Alcohol Depend (2012) 0.80
Alternative reinforcer response cost impacts methamphetamine choice in humans. Pharmacol Biochem Behav (2012) 0.80
Relationship between oral D-amphetamine self-administration and ratings of subjective effects: do subjective-effects ratings correspond with a progressive-ratio measure of drug-taking behavior? Behav Pharmacol (2013) 0.80
Sensitization to the cardiovascular but not subject-rated effects of oral cocaine in humans. Biol Psychiatry (2002) 0.80
Influence of escalating alternative reinforcer values on cigarette choice. Behav Processes (2011) 0.79
Behavioral and physiological effects of cocaine in humans following triazolam. Pharmacol Biochem Behav (2003) 0.78
Amphetamine self-administration in light and moderate drinkers. Alcohol Clin Exp Res (2010) 0.78
Relationship between drug discrimination and ratings of subjective effects: implications for assessing and understanding the abuse potential of D-amphetamine in humans. Behav Pharmacol (2013) 0.78
Separate and Combined Effects of Naltrexone and Extended-Release Alprazolam on the Reinforcing, Subject-Rated, and Cardiovascular Effects of Methamphetamine. J Clin Psychopharmacol (2016) 0.78
Abuse Potential of Oral Phendimetrazine in Cocaine-dependent Individuals: Implications for Agonist-like Replacement Therapy. J Addict Med (2016) 0.77
Relationship between intranasal cocaine self-administration and subject-rated effects: predictors of cocaine taking on progressive-ratio schedules. Hum Psychopharmacol (2014) 0.77
Miotic and subject-rated effects of therapeutic doses of tapentadol, tramadol, and hydromorphone in occasional opioid users. Psychopharmacology (Berl) (2013) 0.77
Mu opioid mediated discriminative-stimulus effects of tramadol: an individual subjects analysis. J Exp Anal Behav (2015) 0.75
Behavioral effects of d-amphetamine in humans: influence of subclinical levels of inattention and hyperactivity. Am J Drug Alcohol Abuse (2010) 0.75